J-Pharma Co.,Ltd. (520A) Stock Price & Analysis
520A Stock Chart & Stats
- Day’s Range
- JPY 398.00 - JPY 418.00
- 52-Week Range
- JPY 260.00 - JPY 809.00
- Previous Close
- JPY 419.00
- Volume
- N/A
- Average Volume (3M)
- 228.99K
- Market Cap
- JPY 7.28B
- Enterprise Value
- JPY 1.76B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 0.13
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
J-Pharma Co.,Ltd. News
J-Pharma Finalizes Restricted Stock Issuance and Tweaks Option Exercise Prices
J-Pharma Co.,Ltd. ( ($JP:520A) ) just unveiled an announcement. J-Pharma Co., Ltd., a research-focused pharmaceutical company listed on the Tokyo Stock Exchange Growth Market, leverages stock-based compensation to align directors
520A FAQ
What was J-Pharma Co.,Ltd.’s price range in the past 12 months?
What is J-Pharma Co.,Ltd.’s market cap?
When is J-Pharma Co.,Ltd.’s upcoming earnings report date?
How were J-Pharma Co.,Ltd.’s earnings last quarter?
Is J-Pharma Co.,Ltd. overvalued?
Does J-Pharma Co.,Ltd. pay dividends?
What is J-Pharma Co.,Ltd.’s EPS estimate?
How many shares outstanding does J-Pharma Co.,Ltd. have?
What happened to J-Pharma Co.,Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of J-Pharma Co.,Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
J-Pharma Co.,Ltd.
J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The company conducts functional and structural analysis of selected SLC transporters to support drug discovery, collaborates with academic institutions, and participates in joint research for new pharmaceutical development. It is preparing for clinical trials and global distribution of its drug candidates. The company was founded in 2005 and is based in Yokohama, Japan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Masuhiro Yoshitake
- Employees
- 16
- Website
- www.j-pharma.com
- Address
- 8th Floor, VORT Hamamatsucho II, Tokyo, TY, 105-0013, JP
J-Pharma Co.,Ltd. (520A) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 6 | 9 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 3 | 0 | 7 |
